Publicaciones en las que colabora con CARLOS FÉLIX TORRADO SALMERÓN (10)

2024

  1. Topical Meloxicam Hydroxypropyl Guar Hydrogels Based on Low-Substituted Hydroxypropyl Cellulose Solid Dispersions

    Gels, Vol. 10, Núm. 3

2023

  1. Development of Chitosan/Sodium Carboxymethylcellulose Complexes to Improve the Simvastatin Release Rate: Polymer/Polymer and Drug/Polymer Interactions’ Effects on Kinetic Models

    Polymers, Vol. 15, Núm. 20

  2. Eficacia de nuevos sistemas multiparticulares deezetimiba/atorvastatina en hiperlipidemia severa

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Solid dispersions of atorvastatin with Kolliphor RH40: Enhanced supersaturation and improvement in a hyperlipidemic rat model

    International Journal of Pharmaceutics, Vol. 631

2021

  1. Estudio de diferentes proporciones de chitosán y carboximetilcelulosa para el desarrollo de complejos polielectrolíticos que logren la liberación sostenida de claritromicina en comprimidos

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 183-184

  2. Multiparticulate systems of ezetimibe micellar system and atorvastatin solid dispersion efficacy of low-dose ezetimibe/atorvastatin on high-fat diet-induced hyperlipidemia and hepatic steatosis in diabetic rats

    Pharmaceutics, Vol. 13, Núm. 3

  3. Sistemas multiparticulares de ezetimiba y atorvastatina en el tratamiento de hiperlipidemia inducida en ratas diabéticas

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 253-255

2020

  1. Improvement of the pharmacokinetic/pharmacodynamic relationship in the treatment of invasive aspergillosis with voriconazole. Reduced drug toxicity through novel rapid release formulations

    Colloids and Surfaces B: Biointerfaces, Vol. 193

2019

  1. Submicellar liquid chromatography with fluorescence detection improves the analysis of naproxen in plasma and brain tissue

    Journal of Separation Science, Vol. 42, Núm. 9, pp. 1702-1709

2018

  1. Efficacy, biodistribution, and nephrotoxicity of experimental amphotericin B-deoxycholate formulations for pulmonary aspergillosis

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 7